Company: WHWK
Filing Date: 2025-01-21
Form Type: PREM14A
Source: 0001193125-25-009599
Chunk: 820

Company: Whitehawk Therapeutics, Inc.
Filing Date: 2025-01-21
Form: PREM14A
Chunk 820
---
 [***] to segregate the
Development and Commercialization activities relating to such Competing Product, as applicable, from Development and Commercialization activities with respect to Licensed ADCs and Licensed Products under this Agreement,[***].

1.70 “Senior Executives” means the Chief Executive Officer or General Counsel of Aadi (or their designee) and
the Chief Executive Officer of WuXi Biologics (or their designee).

G-8

1.71“ SEZ6 Program” means WuXi Biologics’ pre-clinicaldevelopment program relating to SEZ6, as licensed to and further Exploited by Aadi hereunder. 1.72“ Sublicensee” means a Third Party that has been granted a right to sell, market, distribute and/or promote Licensed Products in the Territory pursuant to Section 2.2 excluding any distributor, wholesaler or reseller of a Licensed Product who does not market or promote such Licensed Product. 1.73“ Territory” means worldwide. 1.74“ Third Party” means any Person other than a Party or an Affiliate of a Party. 1.75“ Upstream Agreements” means [***]. The Upstream Agreements include those certain agreements listed on Schedule 1.75, which may be updated from time to time by the Parties. 1.76“ U.S.”means the United States of America, including its territories and possessions 1.77“ Valid Claim” means [***]. 1.78 Additional Definitions. Each of the following terms shall have the meaning described in the corresponding section of this Agreement indicated below:

| Term                           |     | Section Defined |
| Aadi                           |     | Preamble        |
| Aadi Indemnitees               |     | Section 14.2    |
| [***]                          |     | [***]           |
| Agreement                      |     | Preamble        |
| Alliance Manager               |     | Section 3.6     |
| BLA                            |     | Section 1.49    |
| CRO Services                   |     | Section 4.1     |
| Closing Payment                |     | Section 7.1(b)  |
| Closing Period                 |     | Section 7.1(b)  |
| Commercial Milestone Event     |     | Section 7.3(a)  |
| Commercial Milestone Payments  |     | Section 7.3(a)  |
| Confidential Information       |     | Section